PregLem Company
PregLem is a Swiss biopharmaceutical company that focuses on developing and selling innovative drugs for women's reproductive medicine.
.jpg)
Headquarters:
Geneva
Total Funding:
$58,248,124
Founded Date:
2006
Employee Number:
11-50
Last Funding Type:
Series B
Investors Number:
4
Last Funding Date:
2007-12-04
Funding Status:
M&A
Industry:
Reproductive Health & Contraception